{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:13:10Z","timestamp":1788459190252,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-05435-0","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:20:03Z","timestamp":1788456003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial resistance patterns, molecular resistance prediction, and treatment outcomes in pediatric Helicobacter pylori infection"],"prefix":"10.1038","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"5435_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(21)00400-4","volume":"6","author":"C Yuan","year":"2022","unstructured":"Yuan, C. et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc. Health 6, 185\u2013194 (2022).","journal-title":"Lancet Child Adolesc. Health"},{"key":"5435_CR2","first-page":"3569","volume":"25","author":"W Li","year":"2022","unstructured":"Li, W. et al. Prevalence of Helicobacter pylori infection and associated risk factors among Chinese children: a meta-analysis. Chin. Gen. Pract. 25, 3569\u20133578 (2022).","journal-title":"Chin. Gen. Pract."},{"key":"5435_CR3","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.3748\/wjg.v16.i41.5181","volume":"16","author":"L Pacifico","year":"2010","unstructured":"Pacifico, L., Anania, C., Osborn, J. F., Ferraro, F. & Chiesa, C. Consequences of Helicobacter pylori infection in children. World J. Gastroenterol. 16, 5181\u20135194 (2010).","journal-title":"World J. Gastroenterol."},{"key":"5435_CR4","first-page":"1352","volume":"9","author":"CD M\u0103rginean","year":"2022","unstructured":"M\u0103rginean, C. D., M\u0103rginean, C. O. & Meli\u021b, L. E. Helicobacter pylori-related extraintestinal manifestations: myth or reality. Children (Basel) 9, 1352 (2022).","journal-title":"Children (Basel)"},{"key":"5435_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","volume":"9","author":"TC Hong","year":"2024","unstructured":"Hong, T. C. et al. Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 9, 56\u201367 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"5435_CR6","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1097\/CM9.0000000000002884","volume":"137","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Zhang, Y. & Du, S. Antibiotic resistance in Helicobacter pylori among children and adolescents in East Asia: a systematic review and meta-analysis. Chin. Med. J. 137, 1926\u20131938 (2024).","journal-title":"Chin. Med. J."},{"key":"5435_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/jpn3.12314","volume":"79","author":"M Homan","year":"2024","unstructured":"Homan, M. et al. Updated joint ESPGHAN\/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J. Pediatr. Gastroenterol. Nutr. 79, 758\u2013785 (2024).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"5435_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/jpn3.70191","volume":"81","author":"C Chan","year":"2025","unstructured":"Chan, C., Bousvaros, A., Goldsmith, J. D., Liu, E. & Bonilla, S. Antimicrobial susceptibility-guided treatment is superior to empiric therapy for Helicobacter pylori infection in children. J. Pediatr. Gastroenterol. Nutr. 81, 1133\u20131141 (2025).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"5435_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03816-y","volume":"22","author":"A Salahi-Niri","year":"2024","unstructured":"Salahi-Niri, A. et al. Global prevalence of Helicobacter pylori antibiotic resistance among children in the World Health Organization regions between 2000 and 2023: a systematic review and meta-analysis. BMC Med. 22, 598 (2024).","journal-title":"BMC Med"},{"key":"5435_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/antibiotics13040357","volume":"13","author":"R Spagnuolo","year":"2024","unstructured":"Spagnuolo, R., Scarlata, G. G. M., Paravati, M. R., Abenavoli, L. & Luzza, F. Change in diagnosis of Helicobacter pylori infection in the treatment-failure era. Antibiotics (Basel) 13, 357 (2024).","journal-title":"Antibiotics (Basel)"},{"key":"5435_CR11","doi-asserted-by":"publisher","first-page":"1410816","DOI":"10.3389\/fgstr.2024.1410816","volume":"3","author":"M Contreras","year":"2024","unstructured":"Contreras, M., Mujica, H. & Garc\u00eda-Amado, M. A. Molecular tools of antibiotic resistance for Helicobacter pylori: an overview in Latin America. Front. Gastroenterol. 3, 1410816 (2024).","journal-title":"Front. Gastroenterol."},{"key":"5435_CR12","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.3346\/jkms.2024.39.e44","volume":"39","author":"M Hasanuzzaman","year":"2024","unstructured":"Hasanuzzaman, M., Bang, C. S. & Gong, E. J. Antibiotic resistance of Helicobacter pylori: mechanisms and clinical implications. J. Korean Med. Sci. 39, e44 (2024).","journal-title":"J. Korean Med. Sci."},{"key":"5435_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diagmicrobio.2016.03.001","volume":"87","author":"JJ Aguilera-Correa","year":"2017","unstructured":"Aguilera-Correa, J. J. et al. Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. Diagn. Microbiol. Infect. Dis. 87, 150\u2013153 (2017).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"5435_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/antibiotics12030618","volume":"12","author":"S Burayzat","year":"2023","unstructured":"Burayzat, S. et al. Antimicrobial resistance molecular mechanisms of Helicobacter pylori in Jordanian children: a cross-sectional observational study. Antibiotics (Basel) 12, 618 (2023).","journal-title":"Antibiotics (Basel)"},{"key":"5435_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11894-025-01021-2","volume":"27","author":"S Bonilla","year":"2025","unstructured":"Bonilla, S. & Jones, N. L. Update on the management of Helicobacter pylori infection in children and adolescents. Curr. Gastroenterol. Rep. 27, 70 (2025).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"5435_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/1751-2980.13265","volume":"25","author":"YY Han","year":"2024","unstructured":"Han, Y. Y., Li, J. Y., Guan, J. L., Liu, M. & Li, P. Y. Application of furazolidone in Helicobacter pylori infection eradication. J. Dig. Dis. 25, 148\u2013155 (2024).","journal-title":"J. Dig. Dis."},{"key":"5435_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/hel.13038","volume":"29","author":"W Xu","year":"2024","unstructured":"Xu, W. et al. Antibiotic resistance of Helicobacter pylori in Chinese children: a multicenter study from 2016 to 2023. Helicobacter 29, e13038 (2024).","journal-title":"Helicobacter"},{"key":"5435_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12383","volume":"22","author":"K Kotilea","year":"2017","unstructured":"Kotilea, K. et al. Eradication rate of Helicobacter pylori infection is directly influenced by adherence to therapy in children. Helicobacter 22, e12383 (2017).","journal-title":"Helicobacter"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05435-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:20:04Z","timestamp":1788456004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-05435-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":18,"alternative-id":["5435"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-05435-0","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. The study was approved by the Ethics Committee of Shengjing Hospital of China Medical University (No. 2025PS1146K). The requirement for informed consent was waived by the Ethics Committee because of the retrospective nature of the study and the use of de-identified clinical data.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}